ZellBios gets new loan and private equity owner

ZellBios, which makes pharmaceutical ingredients, is raising €125m of drawn and undrawn debt to finance its buyout by Deutsche Private Equity.

  • By Olivier Holmey
  • 18 Dec 2013

The company, born of the 2011 merger of Italy’s Farmabios and Germany’s Pharmazell, previously belonged to Ergon Capital.

The all-senior buyout debt consists of a €33m term loan ‘A’, €67m term loan ‘B’, €15m revolver and €10m capex facility. The term loan ‘B’ is priced at 450bp over ...

Please take a trial or subscribe to access this content.

Contact Mark Goodes to discuss your access: mark.goodes@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Share % by Volume
1 Citi 10.72
2 Bank of America Merrill Lynch (BAML) 10.66
3 Credit Suisse 6.45
4 Lloyds Bank 6.42
5 JP Morgan 6.35

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 16 Jan 2017
1 SG Corporate & Investment Banking 1,260.06 2 126,006,164,037.19%
2 Rabobank 1,081.86 1 108,185,922,974.77%
3 Wells Fargo Securities 430.57 1 43,057,020,785.00%
4 SK Securities 192.86 1 19,286,162,593.99%
4 Meritz Financial Group Inc 192.86 1 19,286,162,593.99%